Skip to main content
Cravatex Ltd. logo

Cravatex Ltd. — Investor Relations & Filings

Ticker · 509472 ISIN · INE145E01017 BSE.NS Wholesale and retail trade
Filings indexed 359 across all filing types
Latest filing 2022-12-30 Regulatory Filings
Country IN India
Listing BSE.NS 509472

About Cravatex Ltd.

https://cravatex.com/

Cravatex Ltd. is a retail and distribution company specializing in international sports, lifestyle, and wellness brands. The company operates through two primary segments: sports wear and fitness equipment. It holds the exclusive license to design, manufacture, and distribute FILA products, including footwear, apparel, and accessories, across various regional markets. Additionally, the company manages the Proline Fitness brand, providing a comprehensive range of home and commercial fitness equipment such as treadmills, elliptical trainers, and strength training machines. Cravatex maintains a robust distribution network comprising exclusive brand outlets, multi-brand stores, and e-commerce platforms. Its business model focuses on bridging the gap between global performance brands and diverse consumer segments, catering to both professional athletes and lifestyle-oriented customers through a portfolio of high-quality athletic and wellness products.

Recent filings

Filing Released Lang Actions
Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons, ....
Regulatory Filings
2022-12-30 English
As per intimation received from Link Intime India Private Limited, the Registrar and Share Transfer Agents of the Company, please find attached the details of loss of share certificates ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) regarding the loss of share certificates by a shareholder. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss disclosures. The content is a regulatory disclosure about share certificates, not a financial report, management change, or other types of filings. The document length is short (1879 characters) and it is a formal notification to the exchange. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-12-09 English
Further to our letters dated 19th October, 2022, 21st October, 2022 and 21st November, 2022 we wish to inform you that the Company has completed the sale/disposal of its 100% shareholding ....
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to BSE Limited's Department of Corporate Services, disclosing the sale/disposal of 100% shareholding in a material subsidiary, Cravatex Brands Limited, to another company. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The document is short (1548 characters) and is an announcement of a transaction rather than a detailed financial report or analysis. It does not contain financial statements or detailed management discussion. Therefore, it fits best under Capital/Financing Update (CAP), as it reports a significant change in the company's capital structure through disposal of a subsidiary.
2022-12-02 English
As required under Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we have enclosed the related party ....
Regulatory Filings Classification · 95% confidence The document is a disclosure of related party transactions for the half year ended 30th September 2022, submitted under Regulation 23(9) of the Securities and Exchange Board of India (SEBI) Listing Obligations and Disclosure Requirements Regulations, 2015. It contains detailed tabular data on related party transactions, including values, approvals, and remarks. The document is a regulatory compliance filing specifically about related party transactions, not a full financial report or audit report. It is not an announcement of a report but the actual disclosure itself. This type of document fits best under Regulatory Filings (RNS) as it is a compliance disclosure that does not fall under other specific categories like Annual Report, Interim Report, or Audit Report.
2022-11-26 English
Voting Results along with the Scrutinizer''''s Report for the Postal Ballot ended on November 20, 2022 is attached.
Regulatory Filings
2022-11-21 English
The Board of Directors of the Company at their meeting held today, which started at 5:15 p.m. and concluded at 5.50 p.m., have approved the Unaudited Financial Results (Standalone and Consolidated) ..
Regulatory Filings
2022-11-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.